The major elements of bone pathology in Gaucher disease are a failure of os
teoclast and osteoblast function, resulting in osteopenia and also osteonec
rosis. T lymphocytes have recently been found to be involved in the regulat
ion of osteoblast/osteoclast activity in vitro. In the present report the p
eripheral blood T major lymphocyte subsets were investigated in a group of
genotyped type 1 Gaucher disease patients, A total of 31 patients were stud
ied: 21 non-splenectomized (5 N370S homozygotes) and 10 splenectomized (of
whom 1 was a N370S homozygote). The results show that non-splenectomized pa
tients present a decrease in absolute numbers of peripheral blood T lymphoc
ytes, specially the CD4(+) T subset. However, when patients were analyzed w
ith respect to the presence of bone disease, the number of CD8(+) T lymphoc
ytes was found to be statistically significantly lower in patients presenti
ng bone involvement. Furthermore, lower numbers of CD8(+) T lymphocytes wer
e significantly correlated with higher levels of plasma tartrate resistant
acid phosphatase (TRAP) activity, a putative marker of osteoclast cell acti
vity. These in vivo findings are in agreement with the results reached in v
itro by others. They provide an additional marker of disease severity in Ga
ucher disease. In the group of genotyped Gaucher disease patients, the majo
rity of the N370S homozygous patients presented a clinically milder phenoty
pe, including the absence of bone involvement, confirming earlier reports p
redicting that a number of these patients may remain undiagnosed. Collectiv
ely the homozygosity for the N370S mutation and normal T cell numbers may p
rovide additional markers for the clinical heterogeneity of Gaucher disease
. (C) 1999 Academic Press.